Most Recent Articles by Laurel Ranger
Healthcare interventions should assess the multiple layers of a person's life, rather than simply classifying marginalized groups as vulnerable.
The use of ezogabine, a KCNQ channel opener, may improve depression and anhedonic symptoms in patients with major depressive disorder.
Future studies need to determine whether improvement in cognition with abstinence is associated with improvement in academic and other functional outcomes.
Assuming blame for a medical error may help patients and families heal.
There are several concerns associated with produce prescription programs, despite the benefits to patients.
More Articles by Laurel Ranger
Assortative Mating Among Bipolar Patients in the United States Increases Risk for Illness in OffspringSep 25,2018
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Health and Social Factors Predict Changes in Depressive Symptoms in Women
- ASD Risk on Offspring With Prenatal Use of Medication Affecting Neurotransmitter System
- Effects of Impaired Glucose Metabolism on Lithium and Other Mood Stabilizers
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Polygenic Risk Scores May Predict Antipsychotic Efficacy in Schizophrenia
- Can Examining Marginalization Identify Gaps in Medical or Nutritional Care?
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Vulnerability to Psychosocial Disability in Psychosis
- Behavioral Health Screening Advocated for Teens With Epilepsy